Thorac Cardiovasc Surg 2017; 65(06): 432-441
DOI: 10.1055/s-0036-1580603
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Comparison of Outcomes following Mitral Valve Repair versus Replacement for Chronic Ischemic Mitral Regurgitation: A Meta-Analysis

Deng Yun-dan
1   Department of Cardiovascular Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China
,
Du Wen-jing
2   Department of Gynecology and Obstetrics, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
,
Xiao Xi-jun
1   Department of Cardiovascular Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China
› Author Affiliations
Further Information

Publication History

17 November 2015

23 January 2016

Publication Date:
07 April 2016 (online)

Abstract

Background The selection of mitral valve surgery, including mitral valve repair and mitral valve replacement, is still an important dilemma for patients with chronic ischemic mitral regurgitation. We carry out a meta-analysis to evaluate the effectiveness and safety of mitral valve repair versus replacement for ischemic mitral regurgitation.

Methods We searched PubMed, Embase, the Cochrane Library, and Web of Science to identify studies from their inception to July 2015. A meta-analysis was performed using RevMan 5.3 software (Cochrane Collaboration, Oxford, United Kingdom). A random-effect model was used and sensitivity analysis was performed on studies reporting on operation after 2000, high-quality studies, and those studies reporting on more than 150 patients.

Result A total of 2,324 patients were identified from 10 retrospective studies. Mitral valve repair was associated with a trend toward lower operative mortality (odds ratio [OR] = 0.45; 95% confidence interval [CI]: 0.31–0.65; p < 0.0001) and higher recurrence of mitral regurgitation (OR = 5.89; 95% CI: 3.34–10.39; p < 0.00001). Five-year survival rate was similar between the two groups (OR = 1.20; 95% CI: 0.88–1.65; p = 0.25). No differences in reoperation, the incidence of acute renal failure and acute respiratory failure, the length of ICU stay, and the length of hospital stay were found.

Conclusion Mitral valve repair was associated with lower operative mortality but a higher recurrence of mitral regurgitation compared with mitral valve replacement. Owing to the limited quantity and quality of the included studies, this conclusion still needs to be further confirmed by conducting more high-quality, multicenter randomized controlled trials with large sample size.

 
  • References

  • 1 Piérard LA, Carabello BA. Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment. Eur Heart J 2010; 31 (24) 2996-3005
  • 2 Hickey MS, Smith LR, Muhlbaier LH. , et al. Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation 1988; 78 (3, Pt 2): I51-I59
  • 3 Milano CA, Daneshmand MA, Rankin JS. , et al. Survival prognosis and surgical management of ischemic mitral regurgitation. Ann Thorac Surg 2008; 86 (03) 735-744
  • 4 Silberman S, Oren A, Klutstein MW. , et al. Does mitral valve intervention have an impact on late survival in ischemic cardiomyopathy?. Isr Med Assoc J 2006; 8 (01) 17-20
  • 5 Lorusso R, Gelsomino S, Vizzardi E. , et al; ISTIMIR Investigators. Mitral valve repair or replacement for ischemic mitral regurgitation? The Italian Study on the Treatment of Ischemic Mitral Regurgitation (ISTIMIR). J Thorac Cardiovasc Surg 2013; 145 (01) 128-139 , discussion 137–138
  • 6 Al-Radi OO, Austin PC, Tu JV, David TE, Yau TM. Mitral repair versus replacement for ischemic mitral regurgitation. Ann Thorac Surg 2005; 79 (04) 1260-1267 , discussion 1260–1267
  • 7 Bonacchi M, Prifti E, Maiani M, Frati G, Nathan NS, Leacche M. Mitral valve surgery simultaneous to coronary revascularization in patients with end-stage ischemic cardiomyopathy. Heart Vessels 2006; 21 (01) 20-27
  • 8 Prifti E, Bonacchi M, Frati G, Giunti G, Babatasi G, Sani G. Ischemic mitral valve regurgitation grade II-III: correction in patients with impaired left ventricular function undergoing simultaneous coronary revascularization. J Heart Valve Dis 2001; 10 (06) 754-762
  • 9 MacHaalany J, Sénéchal M, O'Connor K. , et al. Early and late mortality after repair or replacement in mitral valve prolapse and functional ischemic mitral regurgitation: a systematic review and meta-analysis of observational studies. Int J Cardiol 2014; 173 (03) 499-505
  • 10 Dayan V, Soca G, Cura L, Mestres CA. Similar survival after mitral valve replacement or repair for ischemic mitral regurgitation: a meta-analysis. Ann Thorac Surg 2014; 97 (03) 758-765
  • 11 Vassileva CM, Boley T, Markwell S, Hazelrigg S. Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur J Cardiothorac Surg 2011; 39 (03) 295-303
  • 12 Wells G, Shea B, O'Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis: Ottawa Health Research Institute (OHRI) (2006). Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm . [Accessed May 22, 2008]
  • 13 Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001; 135 (11) 982-989
  • 14 Liberati A, Altman DG, Tetzlaff J. , et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62 (10) e1-e34
  • 15 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7 (03) 177-188
  • 16 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315 (7109): 629-634
  • 17 Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med 2001; 20 (04) 641-654
  • 18 Chan V, Ruel M, Mesana TG. Mitral valve replacement is a viable alternative to mitral valve repair for ischemic mitral regurgitation: a case-matched study. Ann Thorac Surg 2011; 92 (04) 1358-1365 , discussion 1365–1366
  • 19 Qiu Z, Chen X, Xu M. , et al. Is mitral valve repair superior to replacement for chronic ischemic mitral regurgitation with left ventricular dysfunction?. J Cardiothorac Surg 2010; 5: 107
  • 20 Magne J, Girerd N, Sénéchal M. , et al. Mitral repair versus replacement for ischemic mitral regurgitation: comparison of short-term and long-term survival. Circulation 2009; 120 (11, Suppl): S104-S111
  • 21 Micovic S, Milacic P, Otasevic P. , et al. Comparison of valve annuloplasty and replacement for ischemic mitral valve incompetence. Heart Surg Forum 2008; 11 (06) E340-E345
  • 22 Mantovani V, Mariscalco G, Leva C, Blanzola C, Cattaneo P, Sala A. Long-term results of the surgical treatment of chronic ischemic mitral regurgitation: comparison of repair and prosthetic replacement. J Heart Valve Dis 2004; 13 (03) 421-428 , discussion 428–429
  • 23 Calafiore AM, Di Mauro M, Gallina S. , et al. Mitral valve surgery for chronic ischemic mitral regurgitation. Ann Thorac Surg 2004; 77 (06) 1989-1997
  • 24 Jacobs JP, Mavroudis C, Jacobs ML. , et al; STS Congenital Database Taskforce; Joint EACTS-STS Congenital Database Committee. What is operative mortality? Defining death in a surgical registry database: a report of the STS Congenital Database Taskforce and the Joint EACTS-STS Congenital Database Committee. Ann Thorac Surg 2006; 81 (05) 1937-1941
  • 25 Saeed G, Gradaus R, Neuzner J. Single coronary artery anomaly without previous myocardial infarction does not cause ischemic mitral insufficiency. Asian Cardiovasc Thorac Ann 2014; 22 (08) 1011-1012
  • 26 Acker MA, Parides MK, Perrault LP. , et al; CTSN. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2014; 370 (01) 23-32
  • 27 Gillinov AM, Faber C, Houghtaling PL. , et al. Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. J Thorac Cardiovasc Surg 2003; 125 (06) 1350-1362
  • 28 Maltais S, Schaff HV, Daly RC. , et al. Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: factors that influence survival. J Thorac Cardiovasc Surg 2011; 142 (05) 995-1001
  • 29 ten Brinke EA, Klautz RJ, Tulner SA. , et al. Clinical and functional effects of restrictive mitral annuloplasty at midterm follow-up in heart failure patients. Ann Thorac Surg 2010; 90 (06) 1913-1920
  • 30 Hung J, Papakostas L, Tahta SA. , et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation 2004; 110 (11) (Suppl. 01) II85-II90
  • 31 Ciarka A, Braun J, Delgado V. , et al. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am J Cardiol 2010; 106 (03) 395-401
  • 32 Kono T, Sabbah HN, Rosman H. , et al. Mechanism of functional mitral regurgitation during acute myocardial ischemia. J Am Coll Cardiol 1992; 19 (05) 1101-1105
  • 33 Bishay ES, McCarthy PM, Cosgrove DM. , et al. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg 2000; 17 (03) 213-221
  • 34 Fattouch K, Lancellotti P, Castrovinci S. , et al. Papillary muscle relocation in conjunction with valve annuloplasty improve repair results in severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2012; 143 (06) 1352-1355
  • 35 Boyd JH. Ischemic mitral regurgitation. Circ J 2013; 77 (08) 1952-1956
  • 36 Nishimura RA, Otto CM, Bonow RO. , et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63 (22) 2438-2488
  • 37 Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56 (02) 455-463
  • 38 Ioannidis JP, Lau J. Can quality of clinical trials and meta-analyses be quantified?. Lancet 1998; 352 (9128): 590-591
  • 39 Ng TT, McGory ML, Ko CY, Maggard MA. Meta-analysis in surgery: methods and limitations. Arch Surg 2006; 141 (11) 1125-1130 , discussion 1131